ANIK
Anika Therapeutics Inc.

637
Mkt Cap
$153.3M
Volume
88,029.00
52W High
$18.07
52W Low
$7.87
PE Ratio
-4.66
ANIK Fundamentals
Price
$10.63
Prev Close
$10.70
Open
$10.67
50D MA
$9.70
Beta
0.90
Avg. Volume
131,617.55
EPS (Annual)
-$3.83
P/B
1.04
Rev/Employee
$416,343.75
$212.61
Loading...
Loading...
News
all
press releases
Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200 Day Moving Average - Here's What Happened
Anika Therapeutics (NASDAQ:ANIK) Stock Crosses Above 200-Day Moving Average - Time to Sell...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Anika Therapeutics (ANIK) Expected to Announce Quarterly Earnings on Thursday
Anika Therapeutics (NASDAQ:ANIK) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·4d ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving Average - What's Next?
Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200-Day Moving Average - Should You Sell...
MarketBeat·12d ago
News Placeholder
Anika Therapeutics Inc. (NASDAQ:ANIK) Short Interest Update
Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totaling...
MarketBeat·20d ago
News Placeholder
Anika Therapeutics Inc. $ANIK Shares Acquired by Capital Management Corp VA
Capital Management Corp VA grew its holdings in Anika Therapeutics Inc. (NASDAQ:ANIK - Free Report) by 34.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·22d ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving Average - Time to Sell?
Anika Therapeutics (NASDAQ:ANIK) Stock Crosses Above 200-Day Moving Average - Time to Sell...
MarketBeat·1mo ago
News Placeholder
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Anika Therapeutics, Inc. (Anika or the Company) (NASDAQ:ANIK) investors concerning the Companys and/or members of...
Business Wire·2mo ago
News Placeholder
Acadian Asset Management LLC Boosts Position in Anika Therapeutics Inc. $ANIK
Acadian Asset Management LLC lifted its position in shares of Anika Therapeutics Inc. (NASDAQ:ANIK - Free Report) by 6.7% in the second quarter, according to its most recent filing with the...
MarketBeat·3mo ago
News Placeholder
Anika Therapeutics (NASDAQ:ANIK) Upgraded at Wall Street Zen
Wall Street Zen upgraded Anika Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·4mo ago
News Placeholder
Barrington Research Forecasts Strong Price Appreciation for Anika Therapeutics (NASDAQ:ANIK) Stock
Barrington Research increased their price target on shares of Anika Therapeutics from $15.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday...
MarketBeat·4mo ago
<
1
2
...
>

Latest ANIK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.